The cofounder and chief scientific officer at Encoded Therapeutics shared preclinical research with the company’s AAV and miRNA platforms.
Stephanie Tagliatela
Advertisement
Articles by Stephanie Tagliatela
Advertisement
Latest Updated Articles
Stephanie Tagliatela on Researching AAV for Lennox-Gastaut, Alzheimer Disease, SCN9a PainPublished: July 23rd 2024 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
Around the Helix: Cell and Gene Therapy Company Updates – October 29, 2025
2
Intellia Puts Phase 3 Trials for Transthyretin Amyloidosis Gene Editing Therapy Nex-Z on Hold Following Grade 4 Liver AE
3
Quarter Century Update: What Lessons Should Guide the Next Generation of Developers and Regulators?
4
Quarter Century Update: What Does the Field Need Most Right Now?
5
